4//SEC Filing
O'Keefe Kenneth W 4
Accession 0001765581-20-000105
CIK 0001232524other
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 7:29 PM ET
Size
7.7 KB
Accession
0001765581-20-000105
Insider Transaction Report
Form 4
O'Keefe Kenneth W
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2020-11-02+22,249→ 29,667 total - Exercise/Conversion
Phantom Stock
2020-11-02−22,249→ 0 totalFrom: 2020-11-02Exp: 2020-11-02→ Ordinary Shares (22,249 underlying)
Holdings
- 4,445(indirect: By Trust)
Ordinary Shares
Footnotes (2)
- [F1]On November 2, 2020, the Reporting Person's 22,249 phantom stock rights under the Issuer's Amended and Restated Directors Deferred Compensation Plan were settled for an equal number of the Issuer's ordinary shares.
- [F2]Shares are held for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001397661
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 7:29 PM ET
- Size
- 7.7 KB